earnings
confidence high
sentiment positive
materiality 0.85
TransMedics Q2 revenue $114.3M (+118% YoY), net income $12.2M, raises FY guidance
TransMedics Group, Inc.
2024-Q2 EPS reported
$0.70
revenue$211,155,000
- Revenue $114.3M (+118% YoY); net income $12.2M ($0.35 diluted EPS) vs net loss $1.0M.
- Gross margin 61% (down from 70% YoY) due to higher service revenue mix.
- Operating expenses $56.8M (incl $7.3M stock comp) vs $37.6M prior year; driven by R&D and growth.
- Raises FY2024 revenue guidance to $425M-$445M (76%-84% growth) from prior $390M-$400M.
- Cash $362.8M as of June 30; owned 15 aircraft, purchased 2 more in July 2024.